In addition, human breast cancer-associated fibroblasts upregulate the canonical AhR target gene, CYP1B1, and proliferate in response to treatment with the AhR ligand, 3-methylcholanthrene (69). This evidence concerns the gene CYP1B1 and breast carcinoma.